New York, May 20, 2021 (GLOBE NEWSWIRE) -- Increasing awareness about importance of encapsulated cells for managing target diseases and increasing advancements in technology are key factors surging market growth
Market size: USD 269 Million in 2020, Market Growth: CAGR of 3.6%, Market Trends: Rising incidences of target diseases
The global live cell encapsulation market size is expected to reach USD 350 million in 2028 and register a CAGR of 3.6%, according to the latest report by Reports and Data. Rising focus on developing novel drug delivery systems considering rising prevalence of chronic diseases is driving global market revenue growth.
Request free sample of this research report at: https://www.reportsanddata.com/sample-enquiry-form/4018
Technological developments in live cell encapsulation and its increasing usage to treat a variety of diseases are increasing its adoption in modern medicine. It is a mechanism that involves combining cells and introducing medications into the patient’s body. Live cells are encased in protective capsules, sized of a headpin. This capsule acts as a barrier against the immune system and allows blood and nutrients to circulate through and nourish the cells. Rising prevalence of chronic diseases, such as diabetes, cardiovascular disorders, and cancer, has increased demand for live cell encapsulation techniques. In addition, factors, such as increasing funding from public as well as private sectors to develop and launch novel products is boosting revenue growth of the live cell encapsulation market.
However, factors including high costs associated with product manufacturing, scarcity of raw materials with superior quality, and availability of better and cost-effective alternative therapies, are expected to limit revenue growth between 2021 and 2028.
To identify the key trends in the industry, click on the link below: https://www.reportsanddata.com/report-detail/live-cell-encapsulation-market
Some key highlights in the report:
- The simple dripping segment is expected to account for substantial revenue growth based on manufacturing techniques during the forecast period, which is attributable to increasing adoption of simple dripping techniques due to features such as simple and time-efficient techniques, product compatibility, and low particle size distribution.
- Based on polymer type, the PAN-PVC segment is expected to account for fastest revenue growth over the forecast period owing to factors including enhanced permeability, biocompatibility, and high mechanical stability.
- The drug delivery segment is projected to maintain its dominance in the global market based on application between 2021 and 2028 owing to factors such as increasing utilization of live cell encapsulation techniques in delivery and rising prevalence of target diseases.
- Asia Pacific market is expected to register fastest revenue CAGR of 3.4% throughout the forecast period owing to factors such as improvement in healthcare facilities, rising prevalence of chronic diseases and availability of funds and grants for developing novel products and techniques in the region.
- Europe is projected to account for substantial growth revenue during the forecast period due to factors such as rising geriatric population in the region ad increasing need for age-related treatments.
List of Top Key Players of Live Cell Encapsulation Market:
- BioTime, Inc. (US)
- Viacyte, Inc. (US)
- Living Cell Technologies Ltd. (Australia)
- Sigilon Therapeutics, Inc. (US)
- Evonik Industries (Germany)
- BÜCHI Labortechnik AG (Germany)
- Blacktrace Holdings Ltd (UK)
- Sernova Corporation (Canada)
- Neurotech Pharmaceuticals, Inc. (US)
- Gloriana Therapeutics (US)
- Kadimastem (Israel)
- Beta-O2 Technologies, Inc. (Israel)
- Defymed (France)
- Altucell, Inc. (US)
Order Now: https://www.reportsanddata.com/checkout-form/4018
For this study, Reports and Data has segmented the global live cell encapsulation market based on Manufacturing Technique, Polymer Type, Application, and Region:
Based On Manufacturing Technique (Revenue, USD Million, 2018 - 2028)
- Simple Dripping
- Electrostatic Dripping
- Liquid Jet Break Up
- Coaxial Airflow
- Vibrating Jet
- Jet Cutting
- Rotating Disk Atomization
Based On Polymer Type (Revenue, USD Million, 2018 - 2028)
- Alginate
- HEMA-MMA
- Chitosan
- Siliceous Encapsulates
- Cellulose Sulfate
- PAN-PVC
- Other Polymers
Based On Application (Revenue, USD Million, 2018 - 2028)
- Drug Delivery
- Regenerative medicine
- Cell Transplantation
- Probiotics
- Research
Based On Region: (Revenue, USD Million, 2018 - 2028)
- North America
- U.S.
- Canada
- Mexico
- Europe
- Germany
- U.K.
- France
- Italy
- Rest Of Europe
- Asia Pacific
- China
- India
- Japan
- South Korea
- Rest of APAC
- Latin America
- Brazil
- Rest of LATAM
- Middle East & Africa
- Saudi Arabia
- UAE
- South Africa
- Rest of MEA
Browse similar research reports:
Organs-on-Chips Market Size, Share & Analysis, By Type (Liver, Kidney, Lung, Heart, Intestines, Gut), By Offering (Product, Service), By Application (Toxicity Testing, Physiological Model), By End User (Academic, Research Institute, Pharma Companies), And By Region Forecast To 2028
Lung In Vitro Model Market Size, Share & Analysis, By Type (2D Models, 3D Models (In-house, Commercial)), Application (Drug Screening, Toxicology, 3D Model Development, Basic Research, Physiologic Research, Stem Cell Research, Regenerative Medicine), And By Region, Forecast To 2028
In Vivo Toxicology Market Size, Share & Analysis, By Product (Animal Models, Reagents & Kits), By Test Type (Chronic, Sub-Acute), By Toxicity Endpoints (Systemic, Immunotoxicity), By Testing Facility (Outsourced, In-House), By End User (Academic & Research Institute, Cros), And By Region, And Forecast To 2028
Blood Preparation Market Size, Share & Analysis, By Product Type (Whole Blood, Blood Components, Blood Derivatives), By Antithrombotic And Anticoagulant Type (Platelet Aggregation Inhibitors, Fibrinolytics, Anticoagulants), By Application (Angina Blood Vessel Complications, Pulmonary Embolism, Thrombocytosis, Renal Impairment, Others), And By Region, Forecast To 2028
Multiplex Assays Market Size, Share And Analysis, By Product (Consumables, Instruments, Software & Services), Type (Nucleic Acid Assay, Protein Assay, Cell-Based Assay), Technology (Flow Cytometry, Luminescence, Fluorescence Detection, Multiplex RT-PCR, Other Technologies), Application (Research & Development, Clinical Diagnostics, Other Diseases), End Use (Pharmaceutical & Biotechnology Companies, Reference Laboratory, Hospitals & Academic Research Institutes, Reference Laboratories), And By Region To 2028
About Reports and Data
Reports and Data is a market research and consulting company that provides syndicated research reports, customized research reports, and consulting services. Our solutions purely focus on your purpose to locate, target and analyze consumer behavior shifts across demographics, across industries and help client’s make a smarter business decision. We offer market intelligence studies ensuring relevant and fact-based research across a multiple industries including Healthcare, Technology, Chemicals, Power and Energy. We consistently update our research offerings to ensure our clients are aware about the latest trends existent in the market. Reports and Data has a strong base of experienced analysts from varied areas of expertise.
Contact Us:
John W
Head of Business Development
Reports and Data | Web: www.reportsanddata.com
Direct Line: +1-212-710-1370
E-mail: sales@reportsanddata.com
Read Full Press Release: https://www.reportsanddata.com/press-release/global-live-cell-encapsulation-market